🧵 3. Shares of Eli Lilly rose 1% in premarket trading following the executive change. The company remains on the FDA's drug shortage list.
You are viewing a single comment's thread from:
🧵 3. Shares of Eli Lilly rose 1% in premarket trading following the executive change. The company remains on the FDA's drug shortage list.